| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |